$CAMP

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (3m)
Win rate (3m)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$CAMPSEC Form 4bearish
Schwab Andrew J. · Camp4 Therapeutics Corp · 3h agono track record yet
Sold 191,865 @ $4.59 avg · $879,719 · 2026-08-19

Form 4: Schwab Andrew J. sold CAMP

Schwab Andrew J. (Director at Camp4 Therapeutics Corp) reported an open-market sale of 191,865 shares of CAMP at an average $4.59, roughly $879,719, in a Form 4 filed 2026-08-21.

View filing on SEC.gov →

End of results.